External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait
Trial
N/A
Completed
Dec. 17, 2023
Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease
Trial
N/A
Unknown
Dec. 14, 2023
The Effects of a Single Session of Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients
Trial
N/A
Unknown
Dec. 14, 2023
Profile of Depressive Symptoms in Parkinsons Disease
Trial
N/A
Completed
Dec. 13, 2023
PatientSpot Formerly Known as ArthritisPower
Trial
N/A
Unknown
Dec. 12, 2023
Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease
Trial
N/A
Completed
Dec. 11, 2023
MOVIN' CARE for PD (Risk Management)
Trial
N/A
Active, not recruiting
Dec. 10, 2023
A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)
Trial
Phase 1
Completed
Dec. 10, 2023
Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.
Trial
N/A
Completed
Dec. 4, 2023
Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes
Trial
N/A
Not yet recruiting
Dec. 4, 2023
Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)
Trial
Phase 1
Unknown
Nov. 30, 2023
The Role of EEG in Identifying Cognitive Changes in Parkinson's Disease
Trial
N/A
Unknown
Nov. 30, 2023
PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's
Trial
N/A
Recruiting
Nov. 29, 2023
RBD Longitudinal as Prognostic for PD
Trial
N/A
Unknown
Nov. 28, 2023
Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Trial
Phase 1
Completed
Nov. 28, 2023
A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease
Trial
Phase 2
Completed
Nov. 28, 2023
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
Trial
Phase 4
Unknown
Nov. 27, 2023